You just read:

QRxPharma's US Commercialisation Partner, Actavis, to be acquired by Watson Pharmaceuticals, Inc.: MoxDuo® IR on track for launch in Q3, 2012

News provided by

QRxPharma

Apr 26, 2012, 08:01 ET